Instant adhesive Quick drying Specific Glue — recall OR/00058/25
EU Safety Gate (RAPEX) · France · 2025-04-25 · Other risk levels
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Le produit contient des cyanoacrylates, ce qui provoque une irritation des yeux et de la peau, mais il n'affiche pas les avertissements et les étiquettes de danger requis. Les utilisateurs ne sont pas correctement informés des dangers encourus lorsque le produit entre en contact avec la peau et les yeux ou s'il est ingéré. Le produit n'est pas conforme au règlement sur la classification, l'étiquetage et l'emballage des substances et des mélanges (CLP).
Action taken by the authority
Type of economic operator taking notified measure
Other
Category of measure
Recall of the product from end users
Date of entry into force
02/05/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Instant adhesive Quick drying Specific Glue
Risk Description (original English): The product contains cyanoacrylates. which causes eye and skin irritation, but does not display the required warnings and hazard labels. Users are not properly informed about the dangers incurred when the product comes into contact with the skin and eyes or if it is ingested.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.